Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
暂无分享,去创建一个
G. Mckhann | A. Moran | I. Nachamkin | H. Ung | J. Griffin | A. Asbury | M. Prendergast | K. Sheikh | T. Ho | M. Nicholson | D. Yoo
[1] G. Mckhann,et al. Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome , 1999, Annals of neurology.
[2] A. Lastovica,et al. Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barré Syndrome Exhibit Mimicry of GM1 Ganglioside , 1998, Infection and Immunity.
[3] G. Mckhann,et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome , 1998, Neurology.
[4] D. Sack,et al. Microtiter Assay for DetectingCampylobacter spp. and Helicobacter pylori with Surface Gangliosides Which Bind Cholera Toxin , 1998, Journal of Clinical Microbiology.
[5] H. Obayashi,et al. Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome , 1997, Journal of the Neurological Sciences.
[6] J. Penner,et al. Diversity of lipopolysaccharide structures in Campylobacter jejuni. , 1997, The Journal of infectious diseases.
[7] A. Lastovica,et al. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. , 1997, The Journal of infectious diseases.
[8] F. Vriesendorp,et al. Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis. , 1997, The Journal of infectious diseases.
[9] R. Hughes,et al. Clinical and epidemiologic features of Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.
[10] J. Buzby,et al. The economic burden of Campylobacter-associated Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.
[11] G. Mckhann,et al. Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.
[12] A. Moran,et al. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. , 1997, The Journal of infectious diseases.
[13] A. Moran,et al. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome , 1997, Infection and immunity.
[14] E. Nielsen,et al. Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine. , 1997, FEMS immunology and medical microbiology.
[15] K. Tadokoro,et al. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain‐Barré syndrome and Fisher's syndrome , 1997, Annals of neurology.
[16] G. Sobue,et al. Axonal pathology in Japanese Guillain-Barré syndrome: a study of 15 autopsied cases. , 1997, Neurology.
[17] A. Lugaresi,et al. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1 a antibodies following Campylobacter enteritis , 1997, Journal of the Neurological Sciences.
[18] R. Hughes,et al. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain–Barré syndrome (GBS) , 1997, Journal of Neuroimmunology.
[19] B. Appelmelk,et al. Review: Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis , 1996 .
[20] G. Mckhann,et al. Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma , 1996, Annals of neurology.
[21] C. Li,et al. Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[22] L. Mermel,et al. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3 , 1996, Infection and immunity.
[23] I. Nachamkin,et al. Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system , 1996, Journal of clinical microbiology.
[24] A. Moran,et al. Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome , 1995 .
[25] R. Vaughan,et al. HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection , 1995, Journal of Neuroimmunology.
[26] A. Moran,et al. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barre syndrome , 1995 .
[27] A. Moran,et al. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. , 1995, European journal of biochemistry.
[28] M. Blaser,et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. , 1995, Brain : a journal of neurology.
[29] G. Mckhann,et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. , 1995, Brain : a journal of neurology.
[30] T. Miyatake,et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome , 1994, Annals of neurology.
[31] Taki,et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope , 1994, Infection and immunity.
[32] A. McDonald,et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure , 1994, Infection and immunity.
[33] A. McDonald,et al. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. , 1994, Biochemistry.
[34] T. Miyatake,et al. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure , 1993, The Journal of experimental medicine.
[35] M. Blaser,et al. Serologic Evidence of Previous Campylobacter jejuni Infection in Patients with the Guillain-Barre Syndrome , 1993, Annals of Internal Medicine.
[36] S. Ostroff,et al. Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States , 1993, Journal of clinical microbiology.
[37] A. McDonald,et al. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. , 1993, European journal of biochemistry.
[38] A. McDonald,et al. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. , 1993, European journal of biochemistry.
[39] M. Blaser,et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China , 1993, Annals of neurology.
[40] T. Saida,et al. Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues , 1993 .
[41] S. D. Mills,et al. Antigenicity of Helicobacter pylori lipopolysaccharides , 1992, Journal of clinical microbiology.
[42] B. Spangler,et al. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. , 1992, Microbiological reviews.
[43] T. Miyatake,et al. Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodies , 1992, Muscle & nerve.
[44] M. Blaser,et al. Campylobacter Jejuni: Current Status and Future Trends , 1992 .
[45] E. Rietschel,et al. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose , 1991, Journal of bacteriology.
[46] J. Kaldor,et al. Guillain-Barré syndrome associated with Campylobacter infection. , 1985, Australian and New Zealand journal of medicine.
[47] L. Kurland,et al. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. , 1984, American journal of epidemiology.
[48] J. Penner,et al. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens , 1980, Journal of clinical microbiology.
[49] M. Mumenthaler,et al. The Landry-Guillain-Barré syndrome Complications, prognosis and natural history in 123 cases , 1977, Journal of the Neurological Sciences.
[50] J. Mcleod,et al. Acute idiopathic polyneuritis A clinical and electrophysiological follow-up study , 1976, Journal of the Neurological Sciences.
[51] Ellen Jo Baron,et al. Manual of clinical microbiology , 1975 .
[52] J. Prineas. Acute idiopathic polyneuritis. An electron microscope study. , 1972, Laboratory investigation; a journal of technical methods and pathology.
[53] R. Adams,et al. THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS , 1969 .
[54] A. Sabin,et al. Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome. , 1969, JAMA.
[55] J. Gatenby,et al. AN ELECTRON MICROSCOPE STUDY , 1957 .
[56] W. Haymaker,et al. THE LANDRY‐GUILLAIN-BARRÉ SYNDROME: A CLINICOPATHOLOGIC REPORT OF FIFTY FATAL CASES AND A CRITIQUE OF THE LITERATURE , 1949, Medicine.
[57] Robert V. Tauxe,et al. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations , 2000 .
[58] G. Mckhann,et al. Human autoimmune neuropathies. , 1998, Annual review of neuroscience.
[59] J W Griffin,et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome , 1996, Journal of neurocytology.
[60] A. McDonald,et al. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. , 1994, Biochemistry.
[61] 黒木 茂一. Campylobacter jejuni strains from patiensts with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues , 1994 .